REG - abrdn Latin American - Announcement regarding Jersey Manager

abrdn Latin American Income FundAnnouncement

28/02/2023 08:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230228:nRSb1951Ra&default-theme=true

RNS Number : 1951R  abrdn Latin American Income Fund Ld  28 February 2023

ABRDN LATIN AMERICAN INCOME FUND LIMITED (the "Company")

LEI Identifier: 549300DN623WEGE2MY04

Announcement regarding Jersey manager

28 February 2023

The Board of abrdn Latin American Income Fund Limited notes the announcement
made today by abrdn plc ("abrdn") of the sale of abrdn Capital Limited
("aCL"), abrdn's discretionary fund management business in Jersey, to LGT (the
"Sale").  The Sale, which is subject to regulatory approvals, includes abrdn
Capital International Limited ("ACIL"), a subsidiary of aCL.

ACIL currently provides the Jersey regulatory manager function to the
Company.  ACIL delegates the investment management of the Company to abrdn
Investments Limited which is carried out by abrdn's London and Sao Paolo based
emerging markets debt and equities teams.  The Sale does not include abrdn
Investments Limited, which will remain within the abrdn group.

The Board wishes to confirm that, notwithstanding the Sale, the investment
management of the Company's portfolio will be retained by the abrdn group and
will continue to be carried out by abrdn via its emerging markets debt and
equities teams.

Arrangements are currently underway to ensure, as a minimum, a timely transfer
of any regulatory Jersey based management and administration functions to
another suitable Jersey based entity. The Company will be making a further
announcement to confirm its new management structure in due course.

abrdn Capital International Limited

Company Secretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  STRGZGZZVNLGFZM